Clinical Trial Update: Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on administration of mesenchymal stem cells in chronic ischemic cardiomyopathy showing completed study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Ischemia

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Chronic Myocardial Ischemia | Phase 2 | Status: COMPLETED